510(k) Report

510(k) · Cleared

Cleared

Gemini XXP-HP

K151298510(k) TraditionalCleared Jul 30, 201576-day reviewClass II21 CFR 876.5990

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Dornier Medtech America · LNS Lithotriptor, Extracorporeal Shock-Wave, Urological

Cleared on Jul 30, 2015 as substantially equivalent to K132672 (Dornier Medtech America, 2013) after a 76-day review. Its family tree reaches back 4 generations to 1984.

Decided
Jul 30, 2015
Review
76 days
Class
Class II
Product code
LNS
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to P840008 (1984). 7 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 4 generations backP840008 Dornier Lithotripter Compact Transportable (DLCT)Dornier Medtech America, Inc. · 1984
  2. 3 generations backK011773 Dornier Lithotripter 140(Doli 140)Dornier · 2001
  3. 2 generations backK121656 Gemini LithotripterDornier Medtech America, Inc. · 2012
  4. 1 generation backK132672 Extra Corporeal Shockwave LithotripterDornier Medtech America · 2013
  5. This deviceK151298 Gemini XXP-HPDornier Medtech America · 2015
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4P840008Dornier Lithotripter Compact Transportable (DLCT)Dornier Medtech America, Inc.1984—
−3K011773Dornier Lithotripter 140(Doli 140)Dornier2001—
−2K121656Gemini LithotripterDornier Medtech America, Inc.2012—
−1K132672Extra Corporeal Shockwave LithotripterDornier Medtech America2013—
0 (this device)K151298Gemini XXP-HPDornier Medtech America2015—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198810
200120
FIG. 1 — Lineage of K151298, 1984–2015Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LNS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LNS device

  1. #1 K252913 Break Wavescore 15.5 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K132672Extra Corporeal Shockwave Lithotripter
Summary page 4
…ock wave lithotripters as Class II devices with special controls. The Product Code for these lithotripters is LNS. Predicate Device Dornier Gemini 220 XP Lithotripter (K132672) Reference Devices Storz Modulith SLX-F2 180 (K072788) Siemens Lithoskop/Pulso (K070665) Purpose of the 510(k) Notice The Gem…
Dornier Medtech America2013—
†K072788Storz Modulith Lithotripter SLX-F2-F180KARL STORZ Endoscopy-America, Inc.2007—
†K070665LithoskopSiemens Medical Solutions USA, Inc.2008—
†P840008Dornier Lithotripter Compact Transportable (DLCT)Dornier Medtech America, Inc.1984—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 31 years and passes through 3 companies; a new generation was cleared every 11.3 years on median.
  • None of the 7 ancestors has a recall.

How does its category compare?

All LNS devices

LNS Lithotriptor, Extracorporeal Shock-Wave, Urological: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.

FDA decisions per year · LNS

1in 2025

2007: 42008: 22009: 12011: 32012: 32013: 22014: 22015: 22017: 22020: 12021: 12023: 22025: 12026 (partial year): 2
2007high 4 (2007) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LNS

111in 2012

2007: 146 days median2011: 307 days median2012: 111 days median
2007high 307 (2011) · low 111 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LNS

1in 2015

2015: 1
2007high 1 (2015) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LNS

61in 2025

2007: 42008: 102009: 22010: 152011: 212012: 202013: 182014: 212015: 222016: 502017: 542018: 592019: 602020: 382021: 552022: 522023: 862024: 402025: 61
2007high 86 (2023) · low 2 (2009)2025

MAUDE reports naming product code LNS, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007414604
20082—010
20091—02
20100—015
20113307021
20123111020
20132—018
20142—021
20152—122
20160—050
20172—054
20180—059
20190—060
20201—038
20211—055
20220—052
20232—086
20240—040
20251—061
20262—0—

What is it indicated for?

The Gemini XXP-HP is indicated for the fragmentation of urinary tract stones, i.e. renal calyceal stones, renal pelvic stones, and upper ureteral stones.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K151298: Gemini XXP-HP.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K151298

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026